Abnormal physiological properties and altered cell wall composition in Streptococcus pneumoniae grown in the presence of clavulanic acid

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 3, 1997, Pages 504-510

  Severin, Anatoly ^a,b   Severina, Elena ^a,c   Tomasz, Alexander ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^c INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBOXYPEPTIDASE; CLAVULANIC ACID; DEOXYCHOLIC ACID; DEXTRO ALANINE DEXTRO ALANINE LIGASE; LYSOZYME; PENICILLIN DERIVATIVE; PEPTIDOGLYCAN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; DRUG BINDING; DRUG MECHANISM; ENZYME INACTIVATION; HYDROLYSIS; MINIMUM INHIBITORY CONCENTRATION; PEPTIDE ANALYSIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0031035788     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.3.504     Document Type: Article

References (29)

1. Cottagnoud, P., and A. Tomasz. 1993. Triggering of pneumococcal auotlysis by lysozyme. J. Infect. Dis. 167:684-690.
2. Garcia, E., J.-L. Garcia, C. Ronda, P. Garcia, and R. Lopez. 1985. Cloning and expression of the pneumococcal autolysin gene in Escherichia coli. Mol. Gen. Genet. 201:225-230.
3. Garcia, J. L., J. M. Sanchez-Puelles, P. Garcia, R. Lopez, C. Ronda, and E. Garcia. 1986. Molecular characterization of an autolysin-defective mutant of Streptococcus pneumoniae. Biochem. Biophys. Res. Commun. 137:614-619.
4. Garcia-Bustos, J., and A. Tomasz. 1990. A biological price of antibiotic resistance: major changes in the peptidoglycan structure of penicillin-resistant pneumococci. Proc. Natl. Acad. Sci. USA 87:5414-5419.
5. Garcia-Bustos, J. F., B. T. Chait, and A. Tomasz. 1987. Structure of the peptide network of pneumococcal peptidoglycan. J. Biol. Chem. 262:15400-15405.
6. Garcia-Bustos, J. F.. and A. Tomasz. 1987. Teichoic acid-containing muropeptides from Streptococcus pneumoniae as substrates for the pneumococcal autolysin. J. Bacteriol. 169:447-453.
7. Ghuysen, J.-M., P. Chorlier, J. Coyette, C. Duez, E. Fonzé, C. Fraipont, C. Goffin, B. Joris, and M. Nguyen-Distèche. 1996. Penicillin and beyond: evolution, protein fold, multimodular polypeptides, and multiprotein complexes Microb. Drug Resist. 2:163-175.
8. Goldstein, F. W. M. Kitzes, and J. F. Acar. 1979. Affect of clavulanic acid and amoxycillin formulation against β-lactamase-producing gram-negative bacteria in urinary tract infections. J. Antimicrob. Chemother. 5:705-709.
9. Greenwood, D. 1980. A type of interaction between clavulanic acid and other β-lactam antibiotics distinct from the β-lactamase inhibition effect, p. 80-83. In G. N. Rolinsin and A. Watson (ed.), Augmentin, clavulanate-potentiated amoxycillin. (Proceedings of the 1st Symposium, July 1980). Excerpta Medica, Amsterdam, The Netherlands.
10. Greenwood, D., F. O'Grady, and P. Baker. 1979. An in vitro evaluation of clavulanic acid, a potent broad-spectrum β-lactamase inhibitor. J. Antimicrob. Chemother. 5:539-547.
11. Hekenbeck, R., and M. Kohiyama. 1982. Purification of penicillin-binding protein 3 from Streptococcus pneumoniae. Eur. J. Biochem. 127:231-236.
12. Hakenbeck, R., S. Tornette, and N. F. Adkinson. 1987. Interaction of non-lytic β-lactams with penicillin binding proteins in Streptococcus pneumoniae. J. Gen. Microbiol. 133:755-760.
13. Holtje, J.-V., and A. Tomasz. 1975. Specific recognition of choline rescues in the cell wall teichoic acid by the N-acetylmuramyl-L-alanine amidase of pneumococcus. J. Biol. Chem. 250:6072-6076.
14. Jabes, D., S. Nachman, and A. Tomasz. 1989. Penicillin binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci. J. Infect. Dis. 159:16-25.
15. Jabes, D., and A. Tomasz. 1989. Lytic and bactericidal activity of FCE 22101. J. Antimicrob. Chemother. 23(Suppl. C):75-83.
16. Klockars, M., S. Reitamo, T. Wever, and Y. Kerttula. 1978. Cerebrospinal fluid lysozyme in bacterial and viral meningitis. Acta Med. Scand. 203:71-74.
17. Lacks, S., and R. D. Hothckiss. 1960. A study of the genetic material determining an enzyme activity in Pneumococcus. Biochem. Biophys. Acta 39:508-518.
18. Munoz, R., J. M. Musser, M. Crain, D. E. Briles, A. Marton, A. J. Parkinson, U. Sorensen, and A. Tomasz. 1992. Geographic distribution of penicillin resistant clones of Streptococcus pneumoniae: characterization by penicillin binding protein profile, surface protein A typing and multilocus enzyme analysis. Clin. Infect. Dis. 15:112-118.
19. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. Nonomura, N., G. S. Giebink, S. K. Juhn, T. Harada, and D. Aeppli. 1991. The pathophysiology of Streptococcus pneumoniae otitis media: kinetics of middle ear biochemical and cytological host responses. Ann. Otol. Rhinol. Laryngol. 100:235-243.
21. Pozzi, G., M. R. Oggioni, and A. Tomasz. 1989. DNA probe for identification of Streptococcus pneumoniae. J. Clin. Microbiol. 27:370-372.
22. Schuster, C., B. Dobrinski, and R. Hakenbeck. 1990. Unusual septum formation in Streptococcus pneumoniae mutants with an alteration in the D,D-carboxypeptidase penicillin-binding protein 3. J. Bacteriol. 172:6499-6505.
23. Selakovich-Chenu, L., L. Seronde, and A. M. Sicard. 1993. The role of penicillin-binding protein 3 (PBP 3) in cefotaxime resistance in Streptococcus pneumoniae. Mol. Gen. Genet. 239:77-80.
24. Severin, A., C. Schuster, R. Hakenbeck, and A. Tomasz. 1992. Altered murein composition in a DD-carboxypeptidase mutant of Streptococcus pneumoniae. J. Bacteriol. 174:5152-5155.
25. Severin, A., and A. Tomasz. 1996. Naturally occurring peptidoglycan variants of Streptococcus pneumoniae. J. Bacteriol. 178:168-174.
26. Sutherland, R., A. S. Beale, R. J. Boon, K. E. Griffin, B. Slocombe, D. H. Stokes, and A. R. White. 1985. Antibacterial activity of ticarcillin in the presence of clavulanate potassium. Am. J. Med. 79(Suppl. 5B):13-24.
27. Tomasz, A. 1979. The mechanism of the irreversible antimicrobial effects of penicillins: how the β-lactam antibiotics kill and lyse bacteria. Annu. Rev. Microbiol. 33:113-137.
28. Williamson, R., R. Hakenbeck, and A. Tomasz. 1980. The penicillin binding proteins of Streptococcus pneumoniae grown under lysis-permissive and lysis-protective (tolerant) conditions. FEMS Lett. 7:127-131.
29. Wise, R., J. M. Andrews, and K. A. Bedford. 1978. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillm. Antimicrob. Agents Chemother. 13:389-393.